glp-1 meds corona Diabetes: GLP-1s might shield lungs from long COVID damage How GLP-1 medications are transforming

Evidence and UK Treatment Options Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and liraglutide, are licensed in the UK for type 2 diabetes and weight management

Ethics statement The studies involving humans were approved by the Institutional Review Board at the University of Texas Health Science Center at San Antonio

Sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors on major liver outcomes in metabolic dysfunction-associated steatotic liver disease

Research progress on the physiological mechanism by which selenium alleviates heavy metal stress in plants: a review